Real-world and biological evidence research on the treatment of chronic kidney disease based on the theory of atrophy in TCM

Study on the real world and biological evidence of Xiaozheng Sanjie method in the treatment of chronic kidney disease based on traditional Chinese medicine flaccidity theory

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100055024

Enrollment

Unknown

Registered

2021-12-30

Start date

2022-01-01

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

Treatment group:Recipe of Traditional Chinese Medicine

Control group:Conventional Treatment

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Stage 3-4 patients who meet the diagnostic criteria specified in the 2012 KDIGO Chronic Kidney Disease (CKD) Clinical Practice Guidelines. 2. Aged 18-75 years. 3. The patients themselves or their guardians have signed the informed consent before participating in the screening.

Exclusion criteria

Exclusion criteria: 1. Acute kidney injury caused by various reasons. 2. Patients with serious primary diseases such as liver and hematopoietic system, serious infections, mental disorders, and malignant tumors. 3. Hemodialysis, peritoneal dialysis, kidney transplantation and other renal replacement therapy patients. 4. Pregnant or lactating patients. 5. Undergoing other clinical experimental studies.

Design outcomes

Primary

Measure	Time frame
Renal function index;	—

Countries

China

Contacts

Public ContactFan Junming

junmingfan@163.com+86 13908199530

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026